Skip to main content
Olivier Civelli

Olivier Civelli

•Professor, Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences and Pharmacy, University of California, Irvine
•Eric L. and Lila D. Nelson Professor of Neuropharmacology, Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences and Pharmacy, University of California, Irvine

Biography

Olivier Civelli, Ph.D., is Eric L. and Lila D. Nelson Professor of Neuropharmacology in the Department of Pharmaceutical Sciences at the School of Pharmaceutical Sciences and Pharmacy, University of California, Irvine, where he also holds a professorship in the Department of Developmental and Cell Biology in the School of Biological Sciences. Civelli received his Ph.D. from the Swiss Federal Institute of Technology in Zurich in 1979. He served as Chair of the Department of Pharmacology at UC Irvine from 2012 to 2019 and was named Distinguished Professor at UC Irvine in 2018. He currently directs the online Master of Science in Pharmacology Program at UC Irvine.

Civelli's research focuses on G protein-coupled receptors (GPCRs) and the discovery of novel neurotransmitters and neuropeptides through reverse pharmacology. His laboratory cloned several dopamine receptor subtypes, including the D2, D4, D5 and D1 receptors, and identified the natural ligands for multiple orphan GPCRs. His work led to the discovery of orphanin FQ/nociceptin and its receptor, melanin-concentrating hormone receptors, neuropeptide S and its receptor, and other neuromodulatory systems. His research has contributed to understanding the molecular mechanisms underlying psychiatric disorders, pain, sleep regulation, and feeding behavior.

Civelli has trained numerous graduate students and postdoctoral fellows who have gone on to faculty positions at institutions worldwide. He has published over 190 research papers and holds 30 patents. He serves on editorial boards for multiple journals and has been a grant reviewer for funding agencies in the United States and internationally. He is an elected Fellow of the American College of Neuropsychopharmacology and was recognized as an ISI Highly Cited Researcher in 2006. Civelli has a particular expertise in the field of pharmaceutical industry. He was vice president at F. Hoffmann La Roche in Basel, Swtizerland for 4 years. He founded two biotechnology companies and has served on scientific advisory boards for pharmaceutical companies.

Return to top

Education

  • Diplome sc. nat, Swiss Federal Institute of Technology, Zurich, Switzerland, 1973
  • Ph.D., Swiss Federal Institute of Technology, Zurich, Switzerland, 1979
Return to top

Distinctions

  • ISI Highly Cited Researcher, 2006
  • Member of the NIH College of CSR Reviewers, 2010
  • Visiting Professorship for Senior International Scientists, Chinese Academy of Sciences, 2011
  • Chinese Academy of Sciences President's International Fellowship Initiative for Visiting Scientists, 2015-2017
  • Fellow, American College of Neuropsychopharmacology
  • Established Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD), 1992, 2010
  • Astellas USA Foundation Research Award, 2004
  • Guest Professorship, Nantong University, China, 2011
  • Distinguished Professor, University of California, Irvine, 2018
Return to top

Areas of Expertise

  • Neuropharmacology
  • Dopamine Receptor Cloning
  • Opioid Peptide Biosynthesis
  • Neuropeptide Gene Expression
  • Orphan GPCR Deorphanization
  • Melanin-Concentrating Hormone Signaling
  • Neuropeptide S Receptor Pharmacology

Recent Publications

Return to top

Most Cited Publications

Return to top

Contact Information

Email: ocivelli@uci.edu

Phone: (949) 824-2522, 4291

Address: 369/353 Med Surge II

Return to top

This profile was created with the help of AI.

Last updated on 10/28/2026.